These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 9592386)
1. Ferrying proteins to the other side. Fernandez T; Bayley H Nat Biotechnol; 1998 May; 16(5):418-20. PubMed ID: 9592386 [No Abstract] [Full Text] [Related]
2. VP22-mediated intercellular transport correlates with enhanced biological activity of MybEngrailed but not (HSV-I) thymidine kinase fusion proteins in primary vascular cells following non-viral transfection. Sheridan PJ; Lawrie A; Crossman DC; Holt CM; Newman CM J Gene Med; 2005 Mar; 7(3):375-85. PubMed ID: 15543525 [TBL] [Abstract][Full Text] [Related]
3. Nanotechnology for drug and gene therapy: the importance of understanding molecular mechanisms of delivery. Labhasetwar V Curr Opin Biotechnol; 2005 Dec; 16(6):674-80. PubMed ID: 16263259 [TBL] [Abstract][Full Text] [Related]
4. Regression of human mammary adenocarcinoma by systemic administration of a recombinant gene encoding the hFlex-TRAIL fusion protein. Wu X; He Y; Falo LD; Hui KM; Huang L Mol Ther; 2001 Mar; 3(3):368-74. PubMed ID: 11273779 [TBL] [Abstract][Full Text] [Related]
9. Protein therapy-delivery guaranteed. Bayley H Nat Biotechnol; 1999 Nov; 17(11):1066-7. PubMed ID: 10545909 [No Abstract] [Full Text] [Related]
10. HVJ envelope vector, a versatile delivery system: its development, application, and perspectives. Zhang Q; Li Y; Shi Y; Zhang Y Biochem Biophys Res Commun; 2008 Aug; 373(3):345-9. PubMed ID: 18588856 [TBL] [Abstract][Full Text] [Related]
11. Drug delivery of oligonucleotides by peptides. Lochmann D; Jauk E; Zimmer A Eur J Pharm Biopharm; 2004 Sep; 58(2):237-51. PubMed ID: 15296952 [TBL] [Abstract][Full Text] [Related]
12. Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery. Mäe M; Langel U Curr Opin Pharmacol; 2006 Oct; 6(5):509-14. PubMed ID: 16860608 [TBL] [Abstract][Full Text] [Related]
13. Selective gene transfer to tumor cells by recombinant Newcastle Disease Virus via a bispecific fusion protein. Bian H; Fournier P; Moormann R; Peeters B; Schirrmacher V Int J Oncol; 2005 Feb; 26(2):431-9. PubMed ID: 15645128 [TBL] [Abstract][Full Text] [Related]